Description
DALFAMPRIDINE 10MG SA TABLETS 60/BOTLE AMPYRA NDC
First action · last action
2011-09-22 · 2011-09-22
Transactions
1
First transaction's obligation
$19,966
Base + all options value (sum of deltas)
$19,966
Extent competed
NOT COMPETED
Other than full & open authority
URGENCY
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
424210 · DRUGS AND DRUGGISTS' SUNDRIES MERCHANT WHOLESALERS
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-09-22+$19,966= $19,966
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-09-22 | +$19,966 | $19,966 | DALFAMPRIDINE 10MG SA TABLETS 60/BOTLE AMPYRA NDC |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI HJ39FBLVE7L5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026P0991 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $43,680 | FY2026 |
| 36C26226P1412 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $38,220 | FY2026 |
| 36C24826P1108 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $54,600 | FY2026 |
| 36C24226P0845 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $46,019 | FY2026 |
| 36C24926P0361 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $36,814 | FY2026 |
| 36C24226P0588 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $46,019 | FY2026 |
Other recipients under 6505 from 689-WEST HAVEN (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24112P1253 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 689-WEST HAVEN | $31,406 | FY2012 |
| VA689A10863 | ROCHE DIAGNOSTICS CORPORATION | 689-WEST HAVEN | $24,477 | FY2011 |
| VA689A10849 | ASTELLAS PHARMA US, INC. | 689-WEST HAVEN | $24,171 | FY2011 |
| VA689A10840 | NORDION (CANADA) INC. | 689-WEST HAVEN | $10,540 | FY2011 |
| VA689A10811 | BAYER HEALTHCARE PHARMACEUTICALS LIMITED LIABILITY COMPANY | 689-WEST HAVEN | $12,915 | FY2011 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA689A10884_3600_-NONE-_-NONE- · retrieved 2026-09-26.